The role of preprocedural monocyte-to-high-density lipoprotein ratio in prediction of atrial fibrillation recurrence after cryoballoon-based catheter ablation

Europace

Volumn 17, Issue 12, 2015, Pages 1807-1815

  Canpolat, Uʇur ^a   Aytemir, Kudret ^b   Yorgun, Hikmet ^b   Şahiner, Levent ^b   Kaya, Ergün Barlş ^b   Çay, Serkan ^a   Topaloʇlu, Serkan ^a   Aras, Dursun ^a   Oto, Ali ^b  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Atrial fibrillation; Cryoablation; Monocyte to HDL ratio; Recurrence

Indexed keywords

HIGH DENSITY LIPOPROTEIN; BIOLOGICAL MARKER;

ADULT; ARTERIOVENOUS FISTULA; ARTICLE; ATRIAL FIBRILLATION; CATHETER ABLATION; CRYOABLATION; FALSE ANEURYSM; FEMALE; FOLLOW UP; HEART TAMPONADE; HEMATOMA; HUMAN; INGUINAL HEMATOMA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PERCUTANEOUS DRAINAGE; PHRENIC NERVE PARALYSIS; PRIORITY JOURNAL; RECURRENT DISEASE; SENSITIVITY AND SPECIFICITY; ACTION POTENTIAL; ADVERSE EFFECTS; AGED; BLOOD; CHI SQUARE DISTRIBUTION; CRYOSURGERY; HEART MUSCLE CONDUCTION SYSTEM; HEART RATE; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

ACTION POTENTIALS; ADULT; AGED; ATRIAL FIBRILLATION; BIOMARKERS; CATHETER ABLATION; CHI-SQUARE DISTRIBUTION; CRYOSURGERY; FEMALE; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; KAPLAN-MEIER ESTIMATE; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; MONOCYTES; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84947501586     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu291     Document Type: Article

References (21)

1. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS/.EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012; 14: 528-606.
2. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines ESCCfP. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010; 12: 1360-420.
3. Oto A, Aytemir K, Canpolat U, Karakulak U, Evranos B, Sahiner L, et al. Pulmonary vein isolation with the cryoballoon technique in atrial fibrillation treatment: single centre experience. Turk Kardiyol Dern Ars. 2013; 41: 299-309.
4. Li J, Solus J, Chen Q, Rho YH, Milne G, Stein CM, et al. Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm. 2010; 7: 438-44.
5. Friedrichs K, Klinke A, Baldus S. Inflammatory pathways underlying atrial fibrillation. Trends Mol Med. 2011; 17: 556-63.
6. Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. Antiinflammatory properties of HDL. Circ Res. 2004; 95: 764-72.
7. Lewis GF, Rader DJ.Newinsights into the regulation ofHDLmetabolismand reverse cholesterol transport. Circ Res. 2005; 96: 1221-32.
8. Watanabe H, Tanabe N, Yagihara N, Watanabe T, Aizawa Y, Kodama M. Association between lipid profile and risk of atrial fibrillation. Circ J. 2011; 75: 2767-74.
9. Kanbay M, Solak Y, Unal HU, Kurt YG, Gok M, Cetinkaya H, et al. Monocyte count/.HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol. 2014; 46: 1619-25.
10. Canpolat U, Aytemir K, Yorgun H, Sahiner L, Kaya EB, Kabakci G, et al. Role of preablation neutrophil/lymphocyte ratio on outcomes of cryoballoon-based atrial fibrillation ablation. Am J Cardiol. 2013; 112: 513-9.
11. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol. 2008; 51: 802-9.
12. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res. 2002; 54: 230-46.
13. Chen MC, Chang JP, Liu WH, Yang CH, Chen YL, Tsai TH, et al. Increased inflammatory cell infiltration in the atrial myocardium of patients with atrial fibrillation. Am J Cardiol. 2008; 102: 861-5.
14. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, MaseriA. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997; 96: 1180-4.
15. Hansson GK. Inflammatory mechanisms in atherosclerosis. J Thromb Haemost. 2009; 7: 328-31.
16. Lambert JM, Lopez EF, Lindsey ML. Macrophage roles following myocardial infarction. Int J Cardiol. 2008; 130: 147-58.
17. Fontes ML, Mathew JP, Rinder HM, Zelterman D, Smith BR, Rinder CS. Multicenter Study of Perioperative Ischemia Research G. Atrial fibrillation after cardiac surgery/.cardiopulmonary bypass is associated with monocyte activation. Anesth Analg. 2005; 101: 17-23.
18. National Cholesterol Education ProgramExpert Panel onDetection E, Treatment of High Blood Cholesterol in A. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002; 106: 3143-421.
19. Diaz-Peromingo JA, Alban-Salgado A, Garcia-Suarez F, Sanchez-Leira J, Saborido-Frojan J, Iglesias-Gallego M. Lipoprotein (a) and lipid profile in patients with atrial fibrillation. Med Sci Monit. 2006; 12: CR122-5.
20. Annoura M, Ogawa M, Kumagai K, Zhang B, Saku K, ArakawaK. Cholesterol paradox in patients with paroxysmal atrial fibrillation. Cardiology. 1999; 92: 21-7.
21. Letsas KP, Weber R, Burkle G, Mihas CC, Minners J, Kalusche D, et al. Pre-Ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation. Europace. 2009; 11: 158-63.